baber/WOPTO huggingface dataset:
Patent EP-4162000-A1 (EP)
Inventor: KITTLE KEVIN JEFFREY
IPC: C09D5/03
Filed: 2021-06-01
Abstract: The invention relates to a powder coating composition comprising a curing system comprising a curable resin and one or more curing additives for curing the curable resin, wherein the powder coating composition comprises: - two or more powder coating components with different contents of curable resin and/or at least one of the one or more curing additives; - in the range of from 0.1 to 25 wt% of a dry-blended inorganic particulate additive C consisting of inorganic components i), ii), and iii), wherein component i) is non-coated aluminium oxide or non-coated silica, component ii) is aluminium hydroxide and/or aluminium oxyhydroxide, and component iii) is silica; and - optionally up to 35 wt% of a further dry-blended inorganic particulate additive D, wherein the total wt% of dry-blended inorganic particulate additives C and D is at most 40 wt%, wherein powder coating components A and B and any further powder coating component have a particle size distribution with a D v 90 of at most 50 µm and a D v 50 of at most 30 µm, and wherein for any combination of two powder coating components the ratio of the D v 50 of one of the powder components to the D v 50 of the other one of the powder coating components is in the range of from 0.8 to 1.2.
Patent EP-4165223-A1 (EP)
Inventor: AUST DENNIS
IPC: C22C21/08
Filed: 2021-06-07
Abstract: L'invention concerne un procédé de fabrication d'une tôle d'alliage d'aluminium pour des éléments de chambre à vide, des vannes ou des ensembles totaux, le procédé comprenant les étapes consistant à : (a) utiliser un matériau de produit de départ de laminage en alliage d'aluminium Al-Mg-Si ayant une composition comprenant, en % en poids, 0,80 % à 1,05 % de Mg, 0,70 % à 1,0 % de Si, 0,70 % à 0,90 % de Mn, jusqu'à 0,20 % de Fe, jusqu'à 0,08 % de Zn, jusqu'à 0,05 % de Cu, jusqu'à 0,03 % de Cr, jusqu'à 0,06 % de Ti, des impuretés inévitables et le reste d'aluminium ; (b) homogénéiser le produit de départ de laminage à une température dans une plage de 550 à 595 °C ; (c) laminer à chaud le produit de départ de laminage homogénéisé en une ou plusieurs étapes de laminage en une tôle laminée à chaud ayant une épaisseur d'au moins 10 mm ; (d) traiter thermiquement en solution (SHT'') la tôle laminée à chaud à une température dans une plage de 540 à 590 °C ; (e) refroidir rapidement la tôle SHT ; (f) étirer la tôle SHT refroidie pour obtenir un allongement permanent de 1 à 5 % ; et (g) faire vieillir artificiellement la tôle étirée.
Patent EP-4173121-A1 (EP)
Title: Integrierte statorvorrichtung für eine elektrische maschine eines schwungmassenspeichers
Inventor: SCHAEDE HENDRIK
IPC: H02K7/02
Filed: 2021-06-21
Abstract: Die Erfindung betrifft eine Statorvorrichtung (1) für eine elektrische Maschine eines Schwungmassenspeichers, mit einer Blechungseinheit (2), mit einer Wicklung (5) und zumindest zwei an die Wicklung (5) angeschlossenen vakuumseitige Motorphasen-Anschlusskabeln (6), mit einer zylindrischen Hülseneinheit (3), an deren äußeren Mantelfläche (3a) die Blechungseinheit (2) angeordnet ist und mit einer Abdichteinheit (7), welche an einer inneren Mantelfläche (3b) der Hülseneinheit (3) angeordnet ist und welche ausgebildet ist, die vakuumseitigen Motorphasen-Anschlusskabel (6) jeweils vakuumdicht an ein jeweiliges umgebungsseitiges Motorphasen-Anschlusskabel (6') anzuschließen, um eine hinsichtlich ihres Bauraumbedarfs verbesserte Statorvorrichtung (1) für eine elektrische Maschine eines Schwungmassenspeichers bereitzustellen.
Patent EP-4165022-A1 (EP)
Title: Inhibiteurs d'apol1 et leur utilisation
Inventor: CAO JINGRONG
IPC: C07D209/08
Filed: 2021-06-11
Abstract: L'invention concerne au moins un composé, un dérivé deutéré ou un sel pharmaceutiquement acceptable choisi parmi des composés de formule (I), des dérivés deutérés de ceux-ci, et des sels pharmaceutiquement acceptables de l'un quelconque de ceux-ci, des compositions les comprenant, ainsi que des procédés de fabrication et d'utilisation de ceux-ci, y compris l'utilisation dans le traitement d'une maladie rénale médiée par APOL1.
Patent EP-4173191-A1 (EP)
Title: Sidelink communication with hybrid automatic retransmission request (harq) feedback transmission in unlicensed spectrum
Inventor: GUBESKYS ARTHUR
IPC: H04L1/18
Filed: 2021-06-23
Abstract: Certain aspects of the present disclosure provide techniques for slot format for sidelink communication. A method that may be performed by a user equipment (UE) includes transmitting a data signal; refraining from transmitting during a gap portion occurring in time after the transmission of the data signal, wherein the gap portion has a duration less than or equal to a threshold; receiving a feedback signal after the gap portion, wherein the feedback signal comprises at least a signal and hybrid automatic retransmission request (HARQ) feedback for the data signal; receiving another signal; and adjusting a gain applied to the other signal based on the signal.
Patent EP-4179441-A1 (EP)
Inventor: WEBSTER MICHAEL
IPC: H04L9/32
Filed: 2021-07-07
Abstract: A method comprises: - receiving (22), by a user device (14), from a verifier device (12), a request for user data; - retrieving (24) a first cryptogram and a decryption key; - sending (26) and (28), to a server (110), the first cryptogram; - retrieving (210) a random and a second cryptogram generated using reference user authentication data concatenated with the random; - sending (212), to the verifier device, the second cryptogram and the random; - storing (214) the reference random; - sending (216), to the user device, the second cryptogram; - decrypting (218) the second cryptogram using the decryption key; - extracting (220) the reference user authentication data and the random; - providing (224), the user device, with user authentication data; - verifying (226) that it matches the reference user authentication data; - providing (228), the verifier device, with the random; - verifying (230) that it matches the reference random; and - authenticating (234) the user data.
Patent EP-4178340-A1 (EP)
Title: Anordnung zur kultivierung und verwertung von biomasse
Inventor: REICHERT WERNER
IPC: C12M1/107
Filed: 2021-07-06
Abstract: Die Erfindung betrifft eine Anordnung (1) zur Kultivierung von Pflanzen und Verwertung von Biomasseabfällen. Die Anordnung (1) umfasst ein aus mehreren Modulen (101, 102,…10N) aufgebautes modulares Gewächshaus (100) mit einer zugeordneten Steuerungs- und Überwachungseinheit (101). Ebenso umfasst die Anordnung (1) eine modulare, zweistufige Biogasanlage (200) mit einer zugeordneten Steuerungs- und Überwachungseinheit (201), wobei in der modularen, zweistufigen Biogasanlage (200) aus Biomasseabfällen ein Biogas erzeugbar ist. Eine kommutative Verbindung (150) existiert zwischen der Steuerungs- und Überwachungseinheit (101) des modularen Gewächshauses (100) und der Steuerungs- und Überwachungseinheit (201) der modularen, zweistufigen Biogasanlage (200).
Patent EP-4189994-A1 (EP)
Inventor: KUNZ ANDREAS
IPC: H04W12/02
Filed: 2021-07-30
Abstract: Sont divulgués ici des appareils, des procédés et des systèmes d'attribution d'identifiant d'équipement utilisateur dynamique. Un appareil (600) comprend un émetteur-récepteur (625) qui reçoit, au niveau d'un équipement utilisateur ("UE"), un identifiant initial pour le dispositif UE en provenance d'un réseau de communication sans fil mobile et un processeur (605) qui génère une pluralité d'identifiants pour le dispositif UE sur la base de l'identifiant initial, chaque identifiant de la pluralité d'identifiants étant généré sur la base d'un identifiant précédent pour former une chaîne d'identifiants, attribue un identifiant qui a été généré en dernier dans la chaîne d'identifiants au dispositif UE, et attribue périodiquement un identifiant différent au dispositif UE à partir de la chaîne d'identifiants, l'identifiant différent comprenant un identifiant dans la chaîne d'identifiants qui est utilisée pour générer l'identifiant qui est actuellement attribué à l'UE.
Patent EP-4104825-A1 (EP)
Title: Pharmaceutical composition for inhibiting inflammatory response comprising hydroxyurea
Inventor: HWANG TAE-HO
IPC: A61K45/06
Filed: 2021-02-15
Abstract: The present invention relates to use of hydroxyurea for preventing, alleviating, or treating systemic inflammatory response syndrome or sepsis. Hydroxyurea, which is the active ingredient of a pharmaceutical composition of the present invention, can control the activity of neutrophils, which are immune cells involved in inflammatory mechanisms in an individual, and thus can protect an individual from side effects or conditions caused by systemic inflammatory responses which can occur due to exposure to microorganisms such as bacteria or viruses. Thus, when the pharmaceutical composition of the present invention is administered to an individual suffering from a systemic inflammatory response, the pharmaceutical composition prevents, alleviates, or treats systemic inflammatory response syndrome or sepsis in the individual and ultimately can remarkably increase the survival rate of the individual. In addition, the composition according to the present invention can be effective in preventing, alleviating, or treating neutrophilia which can occur when exposed to microorganisms such as bacteria or viruses, wherein the viruses include viruses for therapeutic purposes, such as oncolytic viruses, as well as pathogenic viruses such as influenza virus or coronavirus.
Patent EP-4185235-A1 (EP)
Inventor: RUEDISUELI STUART GAVIN
IPC: A46B9/04
Filed: 2021-07-19
Abstract: Disclosed herein are systems and methods for providing personalized oral irrigation. One variation of a method of generating a model of an oral insert including a fluid inlet port, fluid nozzles, manifolds, and a tray configured to retain teeth may comprise the steps of displaying a graphical representation of the oral insert model, generating a geometry of the fluid nozzles based on oral scan data of a jaw, defining a tray surface that encloses the fluid nozzles based on the oral scan data, generating a geometry of the manifolds that connect the fluid inlet port to the fluid nozzles on the graphical representation of the oral insert model. The manifolds are configured to provide a predetermined range of hydraulic pressures to each of the fluid nozzles.
Patent EP-4107506-A1 (EP)
Inventor: MITRA PARTHA P
IPC: G01N1/28
Filed: 2021-02-22
Abstract: The present disclosure relates to systems and methods for facing and quality control decisions in microtomy. In some embodiments, a histology system is provided, which comprises a microtome configured to progressively remove one or more sections from a tissue block, the tissue block comprising a tissue sample embedded in an embedding material; and a vision system associated with the microtome and comprising: an illumination system configured to illuminate the tissue block comprising a tissue sample embedded in an embedding material; an imaging system configured to image the tissue block to generate imaging data associated with the tissue block; and a processor in communication with the vision system, the processor being programed to receive the imaging data and perform facing and quality control analysis.
Patent EP-4111110-A1 (EP)
Title: Système de refroidissement naturel pour système cvc
Inventor: KOPKO WILLIAM LESLIE
IPC: F25B41/00
Filed: 2021-02-26
Abstract: L'invention concerne un système de chauffage, de ventilation et/ou de climatisation (CVC) (100), comprenant une pompe à vitesse variable (112) configurée pour diriger un fluide réfrigéré à travers un circuit de refroidissement naturel (103) du système CVC (100). Le circuit de refroidissement naturel (104) est conçu pour placer le fluide réfrigéré dans une relation d'échange de chaleur avec l'air ambiant. Le système CVC (100) comprend également un échangeur de chaleur (110) configuré pour placer le fluide réfrigéré dans une relation d'échange de chaleur avec un fluide de conditionnement et un dispositif de commande (44) configuré pour faire fonctionner la pompe à vitesse variable (112) sur la base d'un paramètre du système CVC (100).
Patent EP-4110352-A1 (EP)
Inventor: BENSON MICAH
IPC: A61K38/19
Filed: 2021-02-26
Abstract: L'invention concerne des procédés d'activation et de multiplication de lymphocytes infiltrant les tumeurs (LIT) à l'aide de cytokines non conventionnelles. Ces procédés comprennent des techniques d'activation et de multiplication de LIT à l'aide d'approches rationalisées, comprenant des approches à une étape, des approches utilisant des agonistes pour la stimulation, des approches plus appropriées pour la préparation clinique et des approches sans l'exigence de cellules nourricières. L'invention concerne en outre des compositions de populations multipliées de LIT, en plus de populations de LIT multipliées enrichies en phénotype de lymphocytes T de mémoire centrale.
Patent EP-4110235-A1 (EP)
Inventor: STOCKS GREGORY W
IPC: A61F2/00
Filed: 2021-02-27
Abstract: L'invention concerne une prothèse de genou implantable comprenant un composant de tige fémorale, un composant de tige tibiale et un joint articulé ayant au moins un point de pivot de charnière et un axe de rotation limitée, la prothèse de genou implantable ayant un système extenseur prothétique configuré pour simuler un niveau de mouvement naturel pour des patients ayant des systèmes extenseurs compromis.
Patent EP-4193152-A1 (EP)
Inventor: EDFORS FREDRIK
IPC: G01N33/68
Filed: 2021-08-10
Abstract: Disclosed are a mixture comprising at least one internal standard protein, a container comprising the mixture, a method for preparing a container with the mixture, a method for determining the amount of a target protein present in a sample, providing a container comprising the mixture, as well as a kit for carrying out the methods.
Patent EP-4214217-A1 (EP)
Title: Procédés de production de dihydronicotinamide riboside à partir de chlorure de nicotinamide riboside
Inventor: ZAREI AMIN
IPC: C07H1/00
Filed: 2021-09-14
Abstract: L'invention concerne un procédé de production de 1,4-dihydronicotinamide riboside (NRH). Le procédé consiste à obtenir du chlorure de nicotinamide riboside (NRCl) dans une solution liquide ; à ajouter un dithionite de métal dans la solution liquide à une première température ; et à faire réagir le dithionite de métal avec le chlorure de nicotinamide riboside (NRCl) dans la solution liquide à une seconde température pour former un mélange, au moins une partie du mélange comprenant le 1,4-dihydronicotinamide riboside (NRH).
Patent EP-4121191-A1 (EP)
Inventor: LACKNER KLAUS
IPC: B01D45/12
Filed: 2021-03-16
Abstract: An autothermal direct air capture system (ADAC) is disclosed. The ADAC includes a chamber, a water reservoir, and a sorbent that releases water under ambient conditions, binds water under a first moisture level higher than the ambient moisture level, binds CO 2  under ambient conditions, and releases CO 2  under at least one of an elevated temperature and the first moisture level. The ADAC is movable between a capture configuration and a regeneration configuration, the capture configuration including the sorbent being exposed to a gas volume having CO 2  under ambient conditions, the sorbent binding with CO 2  while desorbing water, the sorbent selected so the sorbent material extracts heat while the ADAC is in the capture configuration, resulting in the thermal charging of the sorbent. The regeneration configuration includes the sorbent inside the chamber and in contact with water, the sorbent releasing carbon dioxide while binding water and depositing heat into the chamber.
Patent EP-4148126-A1 (EP)
Title: Immunoevasive anti-tumor adenovirus
Inventor: CHOI JIN-WOO
IPC: C12N7/00
Filed: 2021-03-22
Abstract: The present invention relates to an anti-tumor adenovirus that can evade the in-vivo immune system. The adenovirus having high ability to kill tumor of the present invention, by comprising a nucleic acid encoding a tumor albumin-binding domain, has significantly increased effects of infecting and killing tumor cells, exhibits an increase in binding with albumin to thereby evade in-vivo immune responses, leading to an increase in plasma half-life, is specifically delivered to cancer cells to produce systemic therapeutic effects, and can be topically delivered and has excellent selectivity, resulting in a remarkable effect in anti-tumor efficacy and, therefore, the adenovirus can be advantageously used as an anticancer composition or anticancer adjuvant in various types of cancer.
Patent EP-4130006-A1 (EP)
Inventor: YING HUA
IPC: A61K39/395
Filed: 2021-03-25
Abstract: Provided are an anti-PSMA antibody-Exatecan analogue conjugate and medical use thereof. Specifically, provided is an anti-PSMA antibody-drug conjugate represented by general formula (Pc-L-Y-D), wherein Pc is an anti-PSMA antibody or an antigen-binding fragment thereof.
Patent EP-4100436-A1 (EP)
Inventor: ROBERTSON BRIAN G
IPC: C07K16/20
Filed: 2021-03-19
Abstract: A threshing concave assembly is disclosed having a threshing concave bar wherein the threshing bar is comprised of two threshing surfaces having a dihedral angle relationship relative to each other. In addition, in another aspect the threshing bar can be comprised of two dihedral surfaces whereby one surface face has about 130% greater surface area than its adjacent surface face. Alternatively, one surface face of the threshing bar can be 1.3x wider than its adjacent surface face. In another aspect the threshing bar can be comprised of two dihedral surfaces whereby one surface face has about a 170% greater surface area than its adjacent surface face.
Patent EP-4214639-A1 (EP)
Title: System for pairing an item of data of a uwb transmitter device and a label comprising a graphic code
Inventor: ANTOLINOS LUC
IPC: G06K19/08
Filed: 2021-09-17
Abstract: Disclosed is a system for performing a pairing of at least a first label (ET 1 ) comprising a graphic code (CG 1 ) and a UWB radio transmitter device (ET 1 ) comprising a UWB radio transmission module and a UHF radio reception module for collecting signals in order to electrically power the UWB transmission module, the transmitter device (ET 1 ) comprising a support comprising a zone delimiting a geometric contour making it possible to visually read the graphic code (CG 1 ) of the first label (ET 1 ) when the transmitter device (ET 1 ) is superimposed on the first label, the system comprising a pairing device (D A ) comprising a reader of the first graphic code (CG 1 ) and a UWB receiver for receiving the UWB signal transmitted by the transmitter device (ET 1 ), the pairing device (D A ) comprising a memory.
Patent EP-4131566-A1 (EP)
Title: Secondary battery system
Inventor: NUMADA Naoki
IPC: H01M10/44
Filed: 2021-03-24
Abstract: The purpose of the present disclosure is to provide a secondary battery system capable of controlling charging and discharging so as to avoid a charging state in which the charging and discharging stop position peaks. A secondary battery system according to one aspect of the present disclosure comprises: an electric load 13 connected to a secondary battery 20; and a control device 40 which, in an SOC-dV/dQ curve in which the dV/dQ that is the differential value of the change amount dV of the voltage V of the secondary battery 20 with respect to the change amount dQ of the capacity Q of the secondary battery 20 is plotted with respect to the charged state (SOC) expressed as a percentage of the capacity Q with respect to the fully charged capacity of the secondary battery 20, when at least one peak top SOC range including the peak top charge rate is set, and charging or discharging stops in the peak top SOC range, discharges the secondary battery 20 by the electric load 13 to avoid the peak top SOC range and ends charging or discharging of the secondary battery 20.
Patent EP-4120727-A1 (EP)
Inventor: ZHUO YIBIN
IPC: H04W28/02
Filed: 2021-04-09
Abstract: Embodiments of this application provide a flow control method and an apparatus, and relate to the field of communication, to avoid a packet loss problem caused by link congestion or deterioration. The method is as follows: A first IAB node receives first information from a second IAB node, where the first information indicates buffer statuses of uplink data that respectively corresponds to N BAP routing identifiers in the second IAB node and/or buffer statuses of uplink data that respectively corresponds to M RLC CHs between the second IAB node and the first IAB node. The first IAB node is a child node of the second IAB node, and N and M are integers greater than or equal to 1. The first IAB node performs uplink flow control based on the first information. Embodiments of this application are applied to an IAB network.
Patent EP-4133430-A1 (EP)
Title: Procédé de réalisation d'un calcul quantique
Inventor: CHOQUETTE-POITEVIN ALEXANDRE
IPC: G06N10/00
Filed: 2021-04-08
Abstract: Procédé pouvant réaliser un calcul quantique comprenant, en séquence, l'initialisation d'une pluralité de bits quantiques d'un processeur quantique, l'application d'une séquence de portes à logique quantique sur les bits quantiques conformément à un circuit quantique paramétré qui est basé sur un Ĥproblème hamiltonien à problèmes et au moins un Ĥk hamiltonien supplémentaire qui ne change pas avec un Ĥproblème, et la mesure de la valeur attendue d'un Ĥproblème à l'état final dans l'état final des bits quantiques.
Patent EP-4222170-A1 (EP)
Inventor: SCHINAGL ALEXANDER
IPC: C07K16/24
Filed: 2021-10-01
Abstract: The invention refers to anti-oxMIF antibodies with improved properties such as reduced aggregation potential and reduced hydrophobicity due to selected amino acid substitutions in the light and heavy chain variable domains and optionally increased effector functions due to further substitutions in the heavy chain constant regions, and their use in the treatment of oxMIF-related conditions.
Patent EP-4216915-A1 (EP)
Title: Composition de soin buccodentaire comprenant du houblon et un arôme
Inventor: BAIG ARIF ALI
IPC: A61K8/37
Filed: 2021-09-27
Abstract: Compositions de soin buccodentaire comprenant du houblon et jusqu'à environ 0,20 % d'un arôme d'ester aromatique. Compositions de soin buccodentaire comprenant du houblon et jusqu'à environ 0,20 % de salicylate de méthyle. Compositions de dentifrice sans fluorure comprenant du houblon et jusqu'à environ 0,20 % de salicylate de méthyle. Compositions de dentifrice sans fluorure comprenant du houblon et moins d'environ 0,20 % de salicylate de méthyle.
Patent EP-4232531-A1 (EP)
Inventor: BENNIS HANANE BELMOKADDEM
IPC: C10L1/06
Filed: 2021-10-19
Abstract: An unleaded aviation fuel composition having a MON of at least 99.6, sulfur content of less than 0.05wt%, CHN content of at least 98wt%, less than 2 wt% of oxygen content, an adjusted heat of combustion of at least 43.5 MJ/kg, a vapor pressure in the range of 38 to 49 kPa, comprising a blend comprising: from 5 vol.% to 25 vol.% of toluene having a MON of at least 107; from 0.5 vol.% to 4 vol.% of aniline;from 30 vol% to 70 vol% of at least one alkylate or alkyate blend having an initial boiling range of from 32°C to 60°C and a final boiling range of from 105°C to 140°C, having T40 of less than 99°C, T50 of less than 100°C, T90 of less than 110°C, the alkylate or alkylate blend comprising isoparaffins from 4 to 9 carbon atoms, 3-20vol% of C5 isoparaffins, 3-15vol% of C7 isoparaffins, and 60-90 vol% of C8 isoparaffins, based on the alkylate or alkylate blend, and less than 1 vol% of C10+, based on the alkylate or alkylate blend; from 0.1 vol.% to 10 vol.% of branched alkyl acetate; at least 8 vol% of isopentane, isobutane, or mixture thereof in an amount sufficient to reach a vapor pressure in the range of 38 to 49 kPa; from 2 vol.% to 10 vol.% of mesitylene; wherein the fuel composition contains less than 1 vol% of C8 aromatics. As well as meeting the requirements of the ASTM D910 specification, the unleaded aviation fuel compositions of the present invention exhibit reduced bladder delamination, improved materials compatibility such as reduced elastomer swelling and reduced paint staining, and improved engine endurance.